-
International Journal of Nanomedicine
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo
(3089) Views (796) Full article downloads
Authors: Coleen R Kaiser, Michelle L Flenniken, Eric Gillitzer, Ann L Harmsen, Allen G Harmsen
Published Date January 2007
Volume 2007:2(4) Pages 715 - 733
DOI: http://dx.doi.org/10.2147/IJN.S
Coleen R Kaiser1, Michelle L Flenniken2,3, Eric Gillitzer3,4, Ann L Harmsen1, Allen G Harmsen1, Mark A Jutila1, Trevor Douglas3,5, Mark J Young3,4
1Department of Veterinary Molecular Biology; 2Department of Microbiology; 3Center for Bio-Inspired Nanomaterials; 4Department of Plant Sciences; and 5Department of Chemistry and Biochemistry, Montana State University, Bozeman, Montana, USA
Abstract: Protein cage nanoparticles have the potential to serve as multifunctional cell targeted, imaging and therapeutic platforms for broad applications in medicine. However, before they find applications in medicine, their biocompatibility in vivo needs to be demonstrated. We provide here baseline biodistribution information of two different spherical protein cage nanoplatforms, the 28 nm viral Cowpea chlorotic mottle virus (CCMV) and the 12 nm heat shock protein (Hsp) cage. In naïve and immunized mice both nanoplatforms show similar broad distribution and movement throughout most tissues and organs, rapid excretion, the absence of long term persistence within mice tissue and organs, and no overt toxicity after a single injection. These results suggest that protein cage based nanoparticles may serve as safe, biocompatible, nanoplatforms for applications in medicine.
Keywords: protein cage nanoparticles, Cowpea chlorotic mottle virus, heat shock protein, biodistribution
Readers of this article also read:
Adverse effects of fullerenes on endothelial cells: Fullerenol C60(OH)24 induced tissue factor and ICAM-1 membrane expression and apoptosis in vitro
Nano-vectors for efficient liver specific gene transfer
Problems and barriers of pain management in the emergency department: Are we ever going to get better?
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
New developments in magnetic resonance imaging techniques for shoulder instability in athletes
Amino acid management of Parkinson’s disease: a case study
Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
Gold nanoparticle trapping and delivery for therapeutic applications
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Interested in being a peer-reviewer?
Click here to register.
- Display new articles on your site
Use our widget to show articles on your own site
- Applications of gold nanoparticles in cancer nanotechnology
- Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer
- Gold nanoparticles: From nanomedicine to nanosensing
- Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases




